| Drug Name |
Phosphonatoformate |
| Drug ID |
BADD_D01767 |
| Description |
An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpes viruses and HIV. |
| Indications and Usage |
For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and for treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients. |
| Marketing Status |
approved |
| ATC Code |
J05AD01 |
| DrugBank ID |
DB00529
|
| KEGG ID |
D00579; D02267
|
| MeSH ID |
D017245
|
| PubChem ID |
3414
|
| TTD Drug ID |
D0OT0O
|
| NDC Product Code |
Not Available |
| UNII |
364P9RVW4X
|
| Synonyms |
Foscarnet | Phosphonoformic Acid | Foscarnet Trisodium Salt | Foscarnet Calcium (2:3) Salt | Foscarnet Disodium Salt | Foscarnet Magnesium (2:3) Salt | Trisodium Phosphonoformate | Phosphonoformate | Foscarnet Sodium | Foscarnet Trilithium Salt | Foscarnet Tripotassium Salt | Foscarnet Sodium Hexahydrate | Foscavir | Foscarnet Barium (2:3) Salt | Foscarnet Manganese (2+) (2:3) Salt |
